# EDGAR Filing Document

**Accession Number:** 0001723128
**File Stem:** 0000898432-26-000204
**Filing Date:** 2026-3
**Character Count:** 6729
**Document Hash:** e1ff4e26fa8cbf1bf1b38dd398f81371
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000898432-26-000204.hdr.sgml**: 20260326

**ACCESSION NUMBER**: 0000898432-26-000204

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260326

**DATE AS OF CHANGE**: 20260326

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Amneal Pharmaceuticals, Inc.
- **CENTRAL INDEX KEY:** 0001723128
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-90473
- **FILM NUMBER:** 26800120

**BUSINESS ADDRESS:**
- **BUSINESS PHONE:** (908) 947-3120

**MAIL ADDRESS:**
- **STREET 1:** 400 CROSSING BOULEVARD
- **STREET 2:** 3RD FLOOR
- **CITY:** BRIDGEWATER
- **STATE:** NJ
- **ZIP:** 08807

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Atlas Holdings, Inc.
- **DATE OF NAME CHANGE:** 20171117
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Patel Dipan
- **CENTRAL INDEX KEY:** 0001745437

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**MAIL ADDRESS:**
- **STREET 1:** C/O PATEL PTC, LLC
- **STREET 2:** 100 WEST LIBERTY STREET, 10TH FLOOR
- **CITY:** RENO
- **STATE:** NV
- **ZIP:** 89501

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 5)**

**Amneal Pharmaceuticals, Inc.**

*(Name of Issuer)*

**Class A Common Stock, par value $0.01**

*(Title of Class of Securities)*

**—**

*(CUSIP Number)*

**Christine Krentz**<br>4 Gatehall Drive<br>Parsippany NJ 07054<br>(908) 409-6700

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**12/31/2025**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Patel Dipan** | Name of reporting person<br>**Patel Dipan** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**16904263.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**16904263.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**16904263.00** | Aggregate amount beneficially owned by each reporting person<br>**16904263.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**5.4%** | Percent of class represented by amount in Row (11)<br>**5.4%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Comment for Reporting Person:** The percentage of ownership of the Class A Common Stock by the Reporting Person presented in this Statement is based on 314,629,101 shares of Class A Common Stock outstanding, as disclosed in the New Issuer's Annual Report on Form 10-K, filed on February 27, 2026.

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Class A Common Stock, par value $0.01

**(b) Name of Issuer:**
Amneal Pharmaceuticals, Inc.

**(c) Address of Issuer's Principal Executive Offices:**
400 Crossing Blvd, Bridgewater, NJ, 08807

**Item 4. Purpose of Transaction**

This Amendment No. 5 to Schedule 13D (this "Amendment No. 5") amends and supplements the Schedule 13D filed with the SEC on July 9, 2018 (the "Initial 13D" and, as amended and supplemented through the date of this Amendment No. 5, the "Schedule 13D"), by the Reporting Person relating to Class A Common Stock of the New Issuer. Capitalized terms used but not defined in this Amendment No. 5 shall have the meanings set forth in the Schedule 13D.

Between November 14, 2024 and December 31, 2025, trusts controlled by the Reporting Person sold 6,924,729 shares of Class A Common Stock in open market transactions at prices per share between $7.74 and $12.42.

**Item 5. Interest in Securities of the Issuer**

**(a)**
—

**(b)**
The following sets forth, as of the date of this Schedule 13D, the aggregate number of shares of Class A Common Stock and percentage of Class A Common Stock beneficially owned by the Reporting Person, as well as the number of shares of Class A Common Stock as to which the Reporting Person has the sole power to vote or to direct the vote, shared power to vote or to direct the vote, sole power to dispose or to direct the disposition, or shared power to dispose or to direct the disposition of, as of the date hereof, based on 314,629,101 shares of Class A Common Stock outstanding, as disclosed in the New Issuer's Annual Report on Form 10-K, filed on February 27, 2026:

Reporting Person - Dipan Patel
Amount Beneficially Owned - 16,904,263
Percent of Class - 5.4
Sole power to vote or to direct the vote - 16,904,263
Shared power to vote or to direct the vote -  0
Sole power to dispose or to direct the disposition - 16,904,263
Shared power to dispose or to direct the disposition - 0

The Reporting Person may be deemed to beneficially own 16,904,263 shares of Class A Common Stock held of record by trusts controlled by the Reporting Person.

**(c)**
The information set forth in Item 4 of this Amendment No. 5 is incorporated by reference herein.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Patel Dipan

**Signature:** Dipan Patel

**Name/Title:** Patel Dipan

**Date:** 03/26/2026